Ferrer India Biotech Private Limited
About Ferrer India Biotech Private Limited
Data last updated:
Ferrer India Biotech Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2013PTC055730. Its GSTIN is 09AACCF9328H1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Kumar Singh and Vijay Kumar Dwivedi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 27/95 C Jagatganj Varanasi, Uttar Pradesh, India – 221002.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.15 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹1,000 (net margin -0.2%) and EBITDA of -₹1,000 (EBITDA margin -0.2%). Revenue has declined at a compounded annual rate (CAGR) of 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ferrer India Biotech Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address27/95 C Jagatganj Varanasi, Uttar Pradesh, India – 221002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ferrer India Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ferrer India Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ferrer India Biotech Private Limited, buy the company report.
Financials of Ferrer India Biotech Private Limited
FY 2025 filings availableFerrer India Biotech Private Limited reported revenue of ₹4.15 Lakh (down 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 21% fall in the latest year. EBITDA rose 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ferrer India Biotech Private Limited, buy the company report.
Board of directors of Ferrer India Biotech Private Limited
Ferrer India Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Singh | Director | 19 Mar 2013 | 13 Years 7 Months | Current |
| Vijay Kumar Dwivedi | Director | 18 Jun 2014 | 12 Years 4 Months | Current |
Peer comparison
Ferrer India Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shoreline Pharmaceutical Private Limited | ₹4.16 Lakh (FY 2025) | -14.0% | Varanasi, Uttar Pradesh, India | |||
| Ferrer India Biotech Private Limitedthis company | ₹4.15 Lakh (FY 2025) | -₹1,000 | -0.2% | -21.0% | Varanasi, Uttar Pradesh, India | |
| Siashmed Lifecare Private Limited | ₹4.13 Lakh (FY 2021) | 1560.0% | New Delhi, Delhi, India | |||
| Innogen Lifesciences Private Limited | ₹4.05 Lakh (FY 2025) | -84.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Ferrer India Biotech Private Limited, buy the company report.
Auditor
Ferrer India Biotech Private Limited is audited by Kislay Thakur & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kislay Thakur & Associates | FY 2017 | 114268 |
Shareholding
The shareholding of Ferrer India Biotech Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ferrer India Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ferrer India Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ferrer India Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ferrer India Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCF9328H1ZE | Uttar Pradesh | Active | 25 Aug 2017 |
To see the full GST registrations and return filing status of Ferrer India Biotech Private Limited, buy the company report.
Recent activity
Ferrer India Biotech Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Manjesh Kumar Upadhyay ceased to be Director on 10 May 2024.
Frequently asked questions
Ferrer India Biotech is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 March 2013 (13+ years old) and is registered under CIN U74120UP2013PTC055730.
Ferrer India Biotech has 2 current directors:
- Sanjay Kumar Singh - Director
- Vijay Kumar Dwivedi - Director
The latest financial statements of Ferrer India Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ferrer India Biotech is 09AACCF9328H1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ferrer India Biotech is U74120UP2013PTC055730. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ferrer India Biotech was incorporated on 19 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Ferrer India Biotech by revenue are Shoreline Pharmaceutical Private Limited, Siashmed Lifecare Private Limited, Innogen Lifesciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Manjesh Kumar Upadhyay ceased to be Director on 10 May 2024. Rajesh Kumar Roy ceased to be Director on 10 May 2024. Vijay Kumar Dwivedi was appointed as Director on 18 Jun 2014. Ferrer India Biotech has 4 board changes on record in total.
The registered office of Ferrer India Biotech is at 2795 C Jagatganj Varanasi, Uttar Pradesh, India – 221002.
Ferrer India Biotech operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Ferrer India Biotech is compliant as of 01 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
